Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Innate DNA-sensing receptors (IDSRs) are a specialized class of pattern recognition receptors (PRRs) responsible for detecting double-stranded DNA (dsDNA) in cellular compartments where it is normally absent, such as the cytoplasm or endosomes, which typically signals viral or bacterial infection (Paludan & Bowie, 2013). Major members of this group include cyclic GMP-AMP synthase (cGAS), Toll-like receptor 9 (TLR9), and Absent in melanoma 2 (AIM2) (Hornung et al., 2009; Sun et al., 2013). Upon binding DNA, these sensors initiate signaling cascades—most notably the cGAS-STING axis—that result in the production of type I interferons and pro-inflammatory cytokines to orchestrate an immune response (Chen et al., 2016). While essential for host defense, dysregulation or chronic activation of these sensors by self-DNA is a primary driver of autoimmune disorders like systemic lupus erythematosus (SLE) and Aicardi-Goutières syndrome (Crow, 2014). Consequently, these receptors are major therapeutic targets; agonists are being investigated to stimulate anti-tumor immunity in oncology, while inhibitors are being developed to treat chronic inflammatory and autoimmune conditions (Corrales et al., 2015).
Modulation of the cGAS-STING pathway to induce or suppress Type I Interferons; Antagonism of endosomal TLR9 to reduce inflammatory signaling; Activation of the AIM2 inflammasome to induce IL-1 beta secretion.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate DNA-sensing receptor (IDSRs).